Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TTHWZMR)

DTT Name Integrin alpha-5/beta-1 (ITGA5/B1)
Gene Name ITGA5/B1
DTT Type
Clinical trial target
 [1]
UniProt ID
ITAV_HUMAN-ITB1_HUMAN
TTD ID
T63206

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
1 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
PLN-74809 DMQDN46 Idiopathic pulmonary fibrosis CB03.4 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 Dual inhibition of alpha(v)beta(6) and alpha(v)beta(1) reduces fibrogenesis in lung tissue explants from patients with IPF. Respir Res. 2021 Oct 19;22(1):265.